Justin Cross
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Avid nutrient consumption is a metabolic hallmark of cancer and leads to regional depletion of key metabolites within the tumor microenvironment (TME). Cancer cells consequently employ diverse strategies to acquire the fuels needed for growth, including bulk uptake of the extracellular medium by macropinocytosis. Here, we show that breast and pancreatic cancer cells macropinocytically internalize extracellular DNA (exDNA), an abundant component of the TME, and deliver it to lysosomes for degradation. This provides a supply of nucleotides that sustains growth when de novo biosynthesis is impaired by glutamine restriction or pharmacological blockade. Mechanistically, this process is dependent on the non-redundant lysosomal equilibrative nucleoside transporter SLC29A3 (ENT3), which mediates the export of nucleosides from the lysosomal lumen into the cytosol. Accordingly, genetic ablation of SLC29A3 or pharmacological disruption of lysosomal function prevents exDNA scavenging and potently sensitizes breast tumors to antimetabolite chemotherapy in vivo . These findings reveal a previously unrecognized nutrient acquisition pathway through which cancer cells recycle exDNA into metabolic building blocks and highlight SLC29A3 as a mediator of metabolic flexibility and a potential target to improve chemotherapy response.
Year:
2025
Lipids and their modifying enzymes regulate diverse features of the tumor microenvironment and cancer progression. The secreted enzyme autotaxin (ATX) hydrolyzes extracellular lysophosphatidylcholine to generate the multifunctional lipid mediator lysophosphatidic acid (LPA) and supports the growth of several tumor types, including pancreatic ductal adenocarcinoma (PDAC). Here we show that ATX suppresses the accumulation of eosinophils in the PDAC microenvironment. Genetic or pharmacologic ATX inhibition increased the number of intratumor eosinophils, which promote tumor cell apoptosis locally and suppress tumor progression. Mechanistically, ATX suppresses eosinophil accumulation via an autocrine feedback loop, wherein ATX–LPA signaling negatively regulates the activity of the AP-1 transcription factor c-Jun, in turn suppressing the expression of the potent eosinophil chemoattractant CCL11 (eotaxin-1). Eosinophils were identified in human PDAC specimens, and rare individuals with high intratumor eosinophil abundance had the longest overall survival. Together with recent findings, this study reveals the context-dependent, immune-modulatory potential of ATX–LPA signaling in cancer.
Year:
2024
Purpose: Sustained minimal residual disease (MRD) negativity is associated with long-term survival in multiple myeloma. The gut microbiome is affected by diet, and in turn can modulate host immunity, for example through production of short-chain fatty acids including butyrate. We hypothesized that dietary factors affect the microbiome (abundance of butyrate-producing bacteria or stool butyrate concentration) and may be associated with multiple myeloma outcomes. Experimental Design: We examined the relationship of dietary factors (via a food frequency questionnaire), stool metabolites (via gas chromatography–mass spectrometry), and the stool microbiome (via 16S sequencing - ±-diversity and relative abundance of butyrate-producing bacteria) with sustained MRD negativity (via flow cytometry at two timepoints 1 year apart) in myeloma patients on lenalidomide maintenance. The Healthy Eating Index 2015 score and flavonoid nutrient values were calculated from the food frequency questionnaire. The Wilcoxon rank sum test was used to evaluate associations with two-sided P Results: At 3 months, higher stool butyrate concentration ( P = 0.037), butyrate producers ( P = 0.025), and ±-diversity ( P = 0.0035) were associated with sustained MRD negativity. Healthier dietary proteins, (from seafood and plants), correlated with butyrate at 3 months ( P = 0.009) and sustained MRD negativity ( P = 0.05). Consumption of dietary flavonoids, plant nutrients with antioxidant effects, correlated with stool butyrate concentration (anthocyanidins P = 0.01, flavones P = 0.01, and flavanols P = 0.02). Conclusions: This is the first study to demonstrate an association between a plant-based dietary pattern, stool butyrate production, and sustained MRD negativity in multiple myeloma, providing rationale to evaluate a prospective dietary intervention. Watch the interview with Urvi A. Shah, MD, recipient of the inaugural Clinical Cancer Research Early Career Award: https://vimeo.com/992991936
Year:
2024
Collaborators (14)
Andriy Derkach
Associate Attending Biostatistician
Memorial Sloan Kettering Cancer Center
Matthew Pianko
Clinical Associate Professor
University of Michigan
Michael Lukey
Associate Professor
Cold Spring Harbor Laboratory
Ola Landgren
Professor of Medicine
Sylvester Comprehensive Cancer Center, University of Miami
Sergio Giralt
Chief Attending, Adult BMT Service
Memorial Sloan Kettering Cancer Center
Urvi Shah
Assistant Attending, Myeloma Service
Memorial Sloan Kettering Cancer Center
Gunjan Shah
Memorial Sloan Kettering Cancer Center
Gladys Block
University of California, Berkeley
Mara H. Sherman
Memorial Sloan Kettering Cancer Center
Jonathan Peled
Director
Memorial Sloan Kettering Cancer Center
Linda Van Aelst
Professor
Cold Spring Harbor Laboratory
Saad Usmani
Chief Attending
Memorial Sloan Kettering Cancer Center
Paolo Cifani
Associate Research Professor
Cold Spring Harbor Laboratory
Erika Tse-Luen Wee
Research Assistant Professor
Cold Spring Harbor Laboratory
Make your next move.
Prepare your application
Review drafts before you send them.